Showing results (931-940 of 956) with videos related to
Sort By:
Pageof 96
International Journal of Molecular Sciences|February 27, 2026
Smaller Oxygen Nanobubbles More Effectively Suppress Colitis and Colon Carcinogenesis than Larger Oxygen NanobubblesGendensuren Dorjkhorloo, Haruka Okami, Nobutoshi Mutsuki, et al.JCO Precision Oncology|April 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling PathwayKen Saijo, Hiroo Imai, Tomoyuki Iwasaki, et al.Scientific Reports|June 23, 2021
PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancerNaoya Ozawa, Takehiko Yokobori, Katsuya Osone, et al.Scientific Reports|July 7, 2026
Clinical utility of comprehensive genomic profiling tests using MTB management system at a single center in JapanChie Sarudate, Miki Dobashi, Maako Kawamura, et al.Cancer Science|June 14, 2022
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancerKensei Yamaguchi, Keiko Minashi, Daisuke Sakai, et al.The AAPS Journal|April 3, 2025
Survey and Establishment of Points to Consider for Application of Analytical Techniques to Evaluate Protein Aggregates and Insoluble Particles in Biopharmaceuticals: Experiences in Japan Biopharmaceutical ConsortiumHiroko Shibata, Satoshi Saitoh, Masato Kiyoshi, et al.International Journal of Clinical Oncology|July 15, 2023
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022Yuichi Ando, Hiroyuki Nishiyama, Hideki Shimodaira, et al.Cancer Gene Therapy|November 8, 2021
Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of originDai Shimizu, Kenzui Taniue, Yusuke Matsui, et al.JAMA Network Open|December 5, 2022
Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in JapanYoichi Naito, Kuniko Sunami, Hidenori Kage, et al.Nippon Ganka Gakkai Zasshi|July 20, 1999
[Analysis of the long-term prognosis for conjunctival malignant melanomas in Japan]A Matsumoto, T Inatomi, S Kinoshita, et al.Pageof 96